Search research articles
Contact Us
Filters
Showing results (71-80 of 439) with videos related to
Page
of 44
Sort By:
Cancer Discovery
|
March 2, 2026
Transcriptomic Subtypes Are Associated with Clinical Outcomes for Patients with Lung Adenocarcinoma Who Have Never Smoked
Alexander A Azizi, Tej Pandya, Charles Swanton
Cancer Discovery
|
June 13, 2024
Tumor Promoters and Opportunities for Molecular Cancer Prevention
William Hill, Clare E Weeden, Charles Swanton
Biochemical Society Transactions
|
February 17, 2017
Constraints in cancer evolution
Subramanian Venkatesan, Nicolai J Birkbak, Charles Swanton
Nature Reviews. Genetics
|
March 11, 2025
Integrating model systems and genomic insights to decipher mechanisms of cancer metastasis
Michelle M Leung, Charles Swanton, Nicholas McGranahan
Trends in Cell Biology
|
August 17, 2021
Capturing cancer evolution using genetically engineered mouse models (GEMMs)
William Hill, Deborah R Caswell, Charles Swanton
Journal of the National Cancer Institute
|
August 12, 2025
The National Health Service-Galleri multi-cancer screening trial: explanation and justification of unique and important design issues
Peter Sasieni, Charles Swanton, Richard D Neal
Immunity
|
October 11, 2023
Cancer cell-intrinsic mechanisms driving acquired immune tolerance
Ehsan Ghorani, Charles Swanton, Sergio A Quezada
Cancer Discovery
|
July 22, 2017
Tumor Evolution as a Therapeutic Target
Nabil Amirouchene-Angelozzi, Charles Swanton, Alberto Bardelli
The American Journal of Pathology
|
May 28, 2013
Adapting clinical paradigms to the challenges of cancer clonal evolution
Nirupa Murugaesu, Su Kit Chew, Charles Swanton
The EPMA Journal
|
December 4, 2012
Promoting predictive, preventive and personalised medicine: European event of global importance
Olga Golubnitschaja, Charles Swanton, Romano Danesi, et al.
Page
of 44
Search research articles
Search
Showing results (71-80 of 439) with videos related to
Sort By:
Page
of 44
Cancer Discovery
|
March 2, 2026
Transcriptomic Subtypes Are Associated with Clinical Outcomes for Patients with Lung Adenocarcinoma Who Have Never Smoked
Alexander A Azizi, Tej Pandya, Charles Swanton
Cancer Discovery
|
June 13, 2024
Tumor Promoters and Opportunities for Molecular Cancer Prevention
William Hill, Clare E Weeden, Charles Swanton
Biochemical Society Transactions
|
February 17, 2017
Constraints in cancer evolution
Subramanian Venkatesan, Nicolai J Birkbak, Charles Swanton
Nature Reviews. Genetics
|
March 11, 2025
Integrating model systems and genomic insights to decipher mechanisms of cancer metastasis
Michelle M Leung, Charles Swanton, Nicholas McGranahan
Trends in Cell Biology
|
August 17, 2021
Capturing cancer evolution using genetically engineered mouse models (GEMMs)
William Hill, Deborah R Caswell, Charles Swanton
Journal of the National Cancer Institute
|
August 12, 2025
The National Health Service-Galleri multi-cancer screening trial: explanation and justification of unique and important design issues
Peter Sasieni, Charles Swanton, Richard D Neal
Immunity
|
October 11, 2023
Cancer cell-intrinsic mechanisms driving acquired immune tolerance
Ehsan Ghorani, Charles Swanton, Sergio A Quezada
Cancer Discovery
|
July 22, 2017
Tumor Evolution as a Therapeutic Target
Nabil Amirouchene-Angelozzi, Charles Swanton, Alberto Bardelli
The American Journal of Pathology
|
May 28, 2013
Adapting clinical paradigms to the challenges of cancer clonal evolution
Nirupa Murugaesu, Su Kit Chew, Charles Swanton
The EPMA Journal
|
December 4, 2012
Promoting predictive, preventive and personalised medicine: European event of global importance
Olga Golubnitschaja, Charles Swanton, Romano Danesi, et al.
Page
of 44